Please login to the form below

Tcelna

This page shows the latest Tcelna news and features for those working in and with pharma, biotech and healthcare.

Merck KGaA drops Ono-partnered multiple sclerosis drug

It also has a licensing deal in place for Tcelna (imilecleucel-T), a personalised treatment for secondary-progressive MS developed by Opexa Therapeutics that is in phase IIb testing with

Latest news

Currencies hit Merck Serono sales but firm says it is 'on course'

Overall groups sales down to €2.84bn for second quarter of 2013
Merck KGaA to meet 2014 financial targets one year early

and recently-licensed MS drug Tcelna (imilecleucel-T) following the decision to drop brain and lung cancer prospect cilengitide from development in the first quarter.
Merck KGaA and Opexa enter MS deal

Merck KGaA and Opexa enter MS deal. Will develop personalised T-cell based medicine Tcelna. ... During the SPMS trial, patients undergo two annual courses of Tcelna treatment, consisting of five injections per year. “

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest Intelligence

Pharma deals during February 2013

sales. In the other option deal, Merck Serono has acquired an option over Opexa Therapeutics' phase IIb Tcelna (imilecleucel-T) vaccine for MS (for all territories except Japan). ... Tcelna is being developed as a personalised therapy specifically

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Medical Writer – Health Behaviour/ Patient Adherence Agency: Salary TBC

Associate Director: £75, 000-90, 000

Consumer Health Account Director: Circa £60, 000 Gym and More

Account Director: Excellent benefits

Associate Director, Market Access & HEOR – North-West: Negotiable

Associate Medical Director: Highly Competitive

Senior Account Managers - Oxfordshire: Attractive salary and benefits package offered

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Senior Systematic Review Analyst - Oxford: Negotiable

Account Manager, Healthcare Public Affairs: £32, 000 – £40, 000 benefits

Medical/ Scientific Director: Salary TBC

Medical Writers Required – Cheshire: DOE

SENIOR MEDICAL WRITER IN ONCOLOGY: Up to £60, 000.00 pension bonus

Senior Medical Writer: Great salary and benefits

Senior Account Director development role to Business Director, H...: Excellent package

Digital Manager, London – Healthcare Brandcomms, Medcomms, PR: Excellent package

Medical Writers: Competitive Salary and Benefits

Senior Account Manager- Central Oxford and Abingdon: Negotiable

Account Manager, Healthcare Communications: £32, 000 - £40, 000 benefits

SAM – Health Behaviour/ Patient Adherence Healthcare Agency: Salary TBC

Events Manager – Med Comms – Surrey: Salary TBC

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Senior Account Executive, London, Medical Communications: Excellent package

Freelance Account Manager / Senior Account Manager - Medical Edu...: £300 per day

Senior Account Manager: Negotiable

Subscribe to our email news alerts

PMHub

Add my company

Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Innovation in merger control and the impact on the pharmaceutical sector: Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think: Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Quality in Care Diabetes 2018: the best in innovative diabetes care: Awards highlight new evidence-based approaches to improving care...